Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
about
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsLiver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Autophagy and disease: always two sides to a problemSerum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease.Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patientsNutrition and exercise in the management of liver cirrhosisImportance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationOverwhelming postsplenectomy infection due to Mycoplasma pneumoniae in an asplenic cirrhotic patient: case reportPrognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosisNutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy.Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease.Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS.Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect CalorimetryEmerging Roles of Branched-Chain Amino Acid Supplementation in Human Diseases.Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.Branched-chain amino acids as pharmacological nutrients in chronic liver disease.Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis.Early administration of branched-chain amino acid granulesAlbumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma.Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: a systematic review.Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityEffect of branched-chain amino acid supplementation on the oxidized/reduced state of plasma albumin in rats with chronic liver disease.Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma.Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis.Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.Systemic abnormalities in liver disease.Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial.
P2860
Q26772302-A1C28325-4AE3-49D3-B8C3-302FC305C688Q26780309-5C8E7AEB-1D0C-4744-AA19-8698D6E8E306Q26995401-3B19B9D4-AA7A-49E4-AAC4-C4932602E338Q30375016-0BE87A13-785B-47D2-979C-2F9186DEDA78Q33378222-3CD64B92-5D95-4C7B-9FB0-B8F3C8719E4EQ33705346-A708145E-AD10-40A0-B6BE-6BA7AB9F3B98Q33780141-24311D19-870A-4826-BB4D-66DCAC0E3117Q33812148-4257AFC9-AC38-406D-86E4-F73CDCD7A501Q33926062-B2E98D9A-1845-4804-B6F9-F3C58B712E4AQ34549563-06D6B0F2-8DF3-4FA6-8779-552CF1547349Q34605122-F8BFA49C-8A10-4D71-BD91-C71FE131FFE4Q34635693-09FEBAC3-852C-48DF-8F64-DDD77BF8879EQ34856251-300C07D2-4643-423B-8C9E-483371926557Q35040709-E578A59C-C3EA-4B0C-A31F-3F8CC32C3B59Q35703747-4C71BBEA-D400-41A0-A8EC-037A31467D91Q35872118-F169CDCA-499A-46E6-B44A-49505FED1ACBQ36056224-56E7D01F-C723-4F40-9903-7D8B754755F0Q36062956-EA3CAFC5-00ED-4594-8477-8922F83450E9Q36478110-FA07D810-8B2F-4EB4-8D67-E3FF098AD807Q36979805-1016DB8D-C330-4DDF-AE62-5384984B7AC6Q37001748-1F77EACD-9B6F-4C9B-9B4C-86025824D5FDQ37874555-A5592345-667F-41A6-8B68-BE54F50D3803Q37914624-37C9FC73-A896-496B-8B04-36E27A592A06Q38040323-C1A855AF-CD77-4879-B17C-91C7A1914C58Q38042596-0CE2F128-9775-4848-890C-B97970D339D6Q38083035-766F0024-67A3-4C4F-AD7B-64C538ABC66FQ38118780-3971C441-FA03-45A7-A8CE-1A02ED7E5518Q38137216-316B3A23-0089-4C02-B79A-DA23244F68ADQ38165918-C3F062D2-5857-4025-B85E-28624BC7134EQ38198618-E809EDC4-C6A6-49A9-BB1A-3B1D5E7E7E0DQ39995926-9E9437FC-13DC-47ED-BE01-CA54D65C119FQ40443991-A16A459D-42CF-4582-AE7E-453B9364E223Q40684685-0FFAE3CF-73A8-40DA-99B5-4F5922C35152Q41627214-855C09E7-B1CC-4744-909F-6396C9844B4AQ41879085-B15317A6-666B-4B8C-B61B-B6C1F1A84749Q42069435-93E7F6EF-5119-4816-9D73-FE48074713A9Q42513537-C018F392-F5A8-48AC-8E51-4D2B060AE87AQ42623529-E3F10348-B6FE-42D1-A8EB-B52F9AE78582Q43039590-C4554177-0D18-4C6E-AB4C-6B9107D509BCQ43522034-672B1B0F-9031-4492-97E9-069CEF8795E2
P2860
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@ast
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@en
type
label
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@ast
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@en
prefLabel
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@ast
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@en
P2093
P1476
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
@en
P2093
Hideki Fukushima
Hisataka Moriwaki
Makoto Shiraki
Masahiko Kato
Masahiro Tajika
Yoshiyuki Miwa
P304
P356
10.1016/J.BBRC.2003.07.016
P407
P577
2004-01-01T00:00:00Z